Neuroinflammation and white matter pathology in schizophrenia: Systematic review

Schizophrenia Research

Volumn 161, Issue 1, 2015, Pages 102-112

  Najjar, Souhel ^a   Pearlman, Daniel M ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Neuroinflammation; Neuropathology; Schizophrenia; Systematic review; White matter

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; CYTOKINE;

ALZHEIMER DISEASE; APOPTOSIS; ASTROCYTOSIS; BIPOLAR DISORDER; BRAIN SIZE; CELL DENSITY; CINGULATE GYRUS; CORPUS CALLOSUM; DEMYELINATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MACROGLIA; MAJOR DEPRESSION; MICROGLIA; NERVE FIBER; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; OLIGODENDROGLIA; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; WHITE MATTER LESION; BIBLIOGRAPHIC DATABASE; COMPLICATION; GLIA; INFLAMMATION; METABOLISM; PATHOLOGY; STATISTICS AND NUMERICAL DATA; WHITE MATTER;

CYTOKINES; DATABASES, BIBLIOGRAPHIC; HUMANS; INFLAMMATION; NEUROGLIA; SCHIZOPHRENIA; WHITE MATTER;

EID: 84920678605     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.04.041     Document Type: Review

References (146)

1. Anderson S.A., Volk D.W., Lewis D.A. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr. Res. 1996, 19(2-3):111-119.
2. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch. Gen. Psychiatry 1998, 55(3):225-232.
3. Bachmann S., Pantel J., Flender A., Bottmer C., Essig M., Schroder J. Corpus callosum in first-episode patients with schizophrenia-a magnetic resonance imaging study. Psychol. Med. 2003, 33(6):1019-1027.
4. Barley K., Dracheva S., Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 2009, 112(1-3):54-64.
5. Barrientos R.M., Sprunger D.B., Campeau S., Watkins L.R., Rudy J.W., Maier S.F. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J. Neuroimmunol. 2004, 155(1-2):119-126.
6. Bayer T.A., Buslei R., Havas L., Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 1999, 271(2):126-128.
7. Beasley C., Hercher C. Alterations in oligodendrocyte and astrocyte cell populations in prefrontal white matter in schizophrenia and bipolar disorder [abstract]. In: Abstracts of the 66th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry. Biol. Psychiatry 2011, 69(9 Suppl):1-305.
8. Beasley C., Hercher C. Microglial Cell Populations in Prefrontal Grey and White Matter in Schizophrenia and Bipolar Disorder [abstract]. in: Abstracts of the 68th Annual Scientific Meeting of the Society of Biological Psychiatry. San Francisco, California, USA. Biol. Psychiatry 2013, 73(9 Suppl):1S-344S.
9. Beasley C.L., Dwork A.J., Rosoklija G., Mann J.J., Mancevski B., Jakovski Z., et al. Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia. Schizophr. Res. 2009, 109(1-3):159-166.
10. Begre S., Koenig T. Cerebral disconnectivity: an early event in schizophrenia. Neuroscientist 2008, 14(1):19-45.
11. Benros M.E., Nielsen P.R., Nordentoft M., Eaton W.W., Dalton S.O., Mortensen P.B. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry 2011, 168(12):1303-1310.
12. Benros M.E., Eaton W.W., Mortensen P.B. The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis. Biol. Psychiatry 2014, 75(4):300-306.
13. Benros M.E., Pedersen M.G., Rasmussen H., Eaton W.W., Nordentoft M., Mortensen P.B. A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am. J. Psychiatry 2014, 171(2):218-226.
14. Bora E., Fornito A., Radua J., Walterfang M., Seal M., Wood S.J., et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr. Res. 2011, 127(1-3):46-57.
15. Borgwardt S.J., Riecher-Rossler A., Smieskova R., McGuire P.K., Fusar-Poli P. Superior temporal gray and white matter changes in schizophrenia or antipsychotic related effects?. Schizophr. Res. 2009, 113(1):109-110.
16. Borgwardt S.J., Smieskova R., Fusar-Poli P., Bendfeldt K., Riecher-Rossler A. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?. Psychol. Med. 2009, 39(11):1781-1782.
17. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280.
18. Brown A.S., Schaefer C.A., Quesenberry C.P., Liu L., Babulas V.P., Susser E.S. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2005, 162(4):767-773.
19. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 2001, 58(11):1032-1037.
20. Buka S.L., Cannon T.D., Torrey E.F., Yolken R.H. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol. Psychiatry 2008, 63(8):809-815. Collaborative Study Group on the Perinatal Origins of Severe Psychiatric, D.
21. Burns J., Job D., Bastin M.E., Whalley H., Macgillivray T., Johnstone E.C., et al. Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br. J. Psychiatry 2003, 182:439-443.
22. Busse S., Busse M., Schiltz K., Bielau H., Gos T., Brisch R., et al. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?. Brain Behav. Immun. 2012, 26(8):1273-1279.
23. Butovsky O., Bukshpan S., Kunis G., Jung S., Schwartz M. Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol. Cell. Neurosci. 2007, 35(3):490-500.
24. Chen S.J., Chao Y.L., Chen C.Y., Chang C.M., Wu E.C., Wu C.S., et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br. J. Psychiatry 2012, 200(5):374-380.
25. Chew L.J., Fusar-Poli P., Schmitz T. Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev. Neurosci. 2013, 35(2-3):102-129.
26. Connor C.M., Crawford B.C., Akbarian S. White matter neuron alterations in schizophrenia and related disorders. Int. J. Dev. Neurosci. 2011, 29(3):325-334.
27. Cui X., Chopp M., Zacharek A., Ning R., Ding X., Roberts C., et al. Endothelial nitric oxide synthase regulates white matter changes via the BDNF/TrkB pathway after stroke in mice. PLOS ONE 2013, 8(11):e80358.
28. Curčić-Blake B., Nanetti L., van der Meer L., Cerliani L., Renken R., Pijnenborg G.H., et al. Not on speaking terms: hallucinations and structural network disconnectivity in schizophrenia. Brain Struct. Funct. 2013.
29. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 2003, 60(5):443-456.
30. De Peri L., Crescini A., Deste G., Fusar-Poli P., Sacchetti E., Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr. Pharm. Des. 2012, 18(4):486-494.
31. DeLisi L.E., Szulc K.U., Bertisch H., Majcher M., Brown K., Bappal A., et al. Early detection of schizophrenia by diffusion weighted imaging. Psychiatry Res. 2006, 148(1):61-66.
32. Deng W. Neurobiology of injury to the developing brain. Nat. Rev. Neurol. 2010, 6(6):328-336.
33. di Penta A., Moreno B., Reix S., Fernandez-Diez B., Villanueva M., Errea O., et al. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLOS ONE 2013, 8(2):e54722.
34. Di X., Chan R.C., Gong Q.Y. White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: an activation likelihood estimation meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(8):1390-1394.
35. Doorduin J., de Vries E.F., Willemsen A.T., de Groot J.C., Dierckx R.A., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 2009, 50(11):1801-1807.
36. Downhill J.E., Buchsbaum M.S., Wei T., Spiegel-Cohen J., Hazlett E.A., Haznedar M.M., et al. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr. Res. 2000, 42(3):193-208.
37. Doyle C., Deakin J.F.W. Fewer astrocytes in frontal cortex in schizophrenia, depression and bipolar disorder [abstract]. In: Abstracts of the XIth Biennial Winter Workshop on Schizophrenia. Davos, Switzerland, February 24-March 1, 2002. Schizophr. Res. 2002, 53(3 Suppl):1-274.
38. Eastwood S.L., Harrison P.J. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol. Psychiatry 2003, 8(9):769. (821-731).
39. Eastwood S.L., Harrison P.J. Interstitial white matter neuron density in the dorsolateral prefrontal cortex and parahippocampal gyrus in schizophrenia. Schizophr. Res. 2005, 79(2-3):181-188.
40. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163(3):521-528.
41. Ellman L.M., Deicken R.F., Vinogradov S., Kremen W.S., Poole J.H., Kern D.M., et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr. Res. 2010, 121(1-3):46-54.
42. Falkai P., Honer W.G., David S., Bogerts B., Majtenyi C., Bayer T.A. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol. Appl. Neurobiol. 1999, 25(1):48-53.
43. Falke E., Han L.Y., Arnold S.E. Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia. Psychiatry Res. 2000, 93(2):103-110.
44. Fillman S.G., Cloonan N., Catts V.S., Miller L.C., Wong J., McCrossin T., et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 2013, 18(2):206-214.
45. Flynn S.W., Lang D.J., Mackay A.L., Goghari V., Vavasour I.M., Whittall K.P., et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry 2003, 8(9):811-820.
46. Friedman J.I., Davis K.L., Chang L., Ernst T., Tsopelas N.D., Zhong K. Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjects. Schizophr. Res. 2008, 100(1-3):356-358.
47. Friedman J.I., Tang C., Carpenter D., Buchsbaum M., Schmeidler J., Flanagan L., et al. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am. J. Psychiatry 2008, 165(8):1024-1032.
48. Fung S.J., Joshi D., Fillman S.G., Weickert C.S. High white matter neuron density with elevated cortical cytokine expression in schizophrenia. Biol. Psychiatry 2014, 75(4):e5-e7.
49. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int. J. Neuropsychopharmacol. 2008, 11(1):49-61.
50. Gilvarry C.M., Sham P.C., Jones P.B., Cannon M., Wright P., Lewis S.W., et al. Family history of autoimmune diseases in psychosis. Schizophr. Res. 1996, 19(1):33-40.
51. Greicius M.D., Supekar K., Menon V., Dougherty R.F. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb. Cortex 2009, 19(1):72-78.
52. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57(11):1061-1069.
53. Haijma S.V., Van Haren N., Cahn W., Koolschijn P.C., Hulshoff Pol H.E., Kahn R.S. Brain volumes in schizophrenia: a meta-analysis in over 18000 subjects. Schizophr. Bull. 2013, 39(5):1129-1138.
54. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(8):4746-4751.
55. Hashimoto T., Arion D., Unger T., Maldonado-Aviles J.G., Morris H.M., Volk D.W., et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 2008, 13(2):147-161.
56. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J. Neuropathol. Exp. Neurol. 2003, 62(5):441-450.
57. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr. Res. 2007, 93(1-3):160-168.
58. Hof P.R., Haroutunian V., Friedrich V.L., Byne W., Buitron C., Perl D.P., et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 2003, 53(12):1075-1085.
59. Honey C.J., Sporns O., Cammoun L., Gigandet X., Thiran J.P., Meuli R., et al. Predicting human resting-state functional connectivity from structural connectivity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(6):2035-2040.
60. Hoptman M.J., Volavka J., Johnson G., Weiss E., Bilder R.M., Lim K.O. Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol. Psychiatry 2002, 52(1):9-14.
61. Hoptman M.J., D'Angelo D., Catalano D., Mauro C.J., Shehzad Z.E., Kelly A.M., et al. Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophr. Bull. 2010, 36(5):1020-1028.
62. Innocenti G.M., Ansermet F., Parnas J. Schizophrenia, neurodevelopment and corpus callosum. Mol. Psychiatry 2003, 8(3):261-274.
63. Kato T.A., Monji A., Mizoguchi Y., Hashioka S., Horikawa H., Seki Y., et al. Anti-inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?. Mini-Rev. Med. Chem. 2011, 11(7):565-574.
64. Kato T.A., Monji A., Yasukawa K., Mizoguchi Y., Horikawa H., Seki Y., et al. Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia. Schizophr. Res. 2011, 129(2-3):172-182.
65. Katsel P., Byne W., Roussos P., Tan W., Siever L., Haroutunian V. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology 2011, 36(6):1171-1177.
66. Kirkpatrick B., Messias N.C., Conley R.R., Roberts R.C. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J. Nerv. Ment. Dis. 2003, 191(9):563-567.
67. Konrad A., Winterer G. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?. Schizophr. Bull. 2008, 34(1):72-92.
68. Kuswanto C.N., Teh I., Lee T.S., Sim K. Diffusion tensor imaging findings of white matter changes in first episode schizophrenia: a systematic review. Clin. Psychopharmacol. Neurosci. 2012, 10(1):13-24.
69. Leviton A., Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007, 30(9):473-478.
70. Li J., Kale Edmiston E., Chen K., Tang Y., Ouyang X., Jiang Y., et al. A comparative diffusion tensor imaging study of corpus callosum subregion integrity in bipolar disorder and schizophrenia. Psychiatry Res. 2014, 221(1):58-62.
71. Liang M., Zhou Y., Jiang T., Liu Z., Tian L., Liu H., et al. Widespread functional disconnectivity in schizophrenia with resting-state functional magnetic resonance imaging. Neuroreport 2006, 17(2):209-213.
72. Maitra R., Schloesser R., Rosa A., Papiol S., Gaser C., Schachtzabel C., et al. A2 risk allele of interleukin-1β modifies both grey and white matter in temporal lobe in schizophrenia. In: Abstracts of the 2nd European Conference on Schizophrenia Research: from research to practice. September 21-23, 2009. Berlin, Germany. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259(Suppl 1):3-105.
73. Mattiace L.A., Davies P., Dickson D.W. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am. J. Pathol. 1990, 136(5):1101-1114.
74. Matute C., Alberdi E., Domercq M., Sanchez-Gomez M.V., Perez-Samartin A., Rodriguez-Antiguedad A., et al. Excitotoxic damage to white matter. J. Anat. 2007, 210(6):693-702.
75. Meisenzahl E.M., Rujescu D., Kirner A., Giegling I., Kathmann N., Leinsinger G., et al. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am. J. Psychiatry 2001, 158(8):1316-1319.
76. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:20-34.
77. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
78. Miller B.J., Culpepper N., Rapaport M.H., Buckley P. Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:92-100.
79. Miller B.J., Gassama B., Sebastian D., Buckley P., Mellor A. Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2013, 73(10):993-999.
80. Mitelman S.A., Brickman A.M., Shihabuddin L., Newmark R.E., Hazlett E.A., Haznedar M.M., et al. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage 2007, 37(2):449-462.
81. Mitelman S.A., Torosjan Y., Newmark R.E., Schneiderman J.S., Chu K.W., Brickman A.M., et al. Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr. Res. 2007, 92(1-3):211-224.
82. Monji A., Kato T., Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 2009, 63(3):257-265.
83. Monji A., Kato T.A., Mizoguchi Y., Horikawa H., Seki Y., Kasai M., et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:115-121.
84. Mortensen P.B., Norgaard-Pedersen B., Waltoft B.L., Sorensen T.L., Hougaard D., Torrey E.F., et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiatry 2007, 61(5):688-693.
85. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10:43.
86. Olabi B., Ellison-Wright I., McIntosh A.M., Wood S.J., Bullmore E., Lawrie S.M. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol. Psychiatry 2011, 70(1):88-96.
87. Pang Y., Cai Z., Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res. Dev. Brain Res. 2003, 140(2):205-214.
88. Pang Y., Campbell L., Zheng B., Fan L., Cai Z., Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 2010, 166(2):464-475.
89. Pasternak O., Sochen N., Gur Y., Intrator N., Assaf Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 2009, 62(3):717-730.
90. Pasternak O., Westin C.F., Bouix S., Seidman L.J., Goldstein J.M., Woo T.U., et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J. Neurosci. 2012, 32(48):17365-17372.
91. Patel S., Mahon K., Wellington R., Zhang J., Chaplin W., Szeszko P.R. A meta-analysis of diffusion tensor imaging studies of the corpus callosum in schizophrenia. Schizophr. Res. 2011, 129(2-3):149-155.
92. Peters B.D., Blaas J., de Haan L. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?. J. Psychiatr. Res. 2010, 44(15):993-1004.
93. Pfefferbaum A., Sullivan E.V., Hedehus M., Moseley M., Lim K.O. Brain gray and white matter transverse relaxation time in schizophrenia. Psychiatry Res. 1999, 91(2):93-100.
94. Prasad K.M., Upton C., Nimgaonkar V., Keshavan M. Differential susceptibility of white matter tracts for immune mediators in schizophrenia: an integrated DTI study. In: 68th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, San Francisco, CA 2013, 304S.
95. Prata D.P., Papagni S.A., Mechelli A., Fu C.H., Kambeitz J., Picchioni M., et al. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency. Hum. Brain Mapp. 2012, 33(1):143-153.
96. Qiu A., Tuan T.A., Woon P.S., Abdul-Rahman M.F., Graham S., Sim K. Hippocampal-cortical structural connectivity disruptions in schizophrenia: an integrated perspective from hippocampal shape, cortical thickness, and integrity of white matter bundles. Neuroimage 2010, 52(4):1181-1189.
97. Radewicz K., Garey L.J., Gentleman S.M., Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 2000, 59(2):137-150.
98. Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2002, 57(2-3):127-138.
99. Rane S., Kose S., Gore J.C., Heckers S. Altered functional and structural connectivity in a schizophrenia patient with complete agenesis of the corpus callosum. Am. J. Psychiatry 2013, 170(1):122-123.
100. Reis Marques T., Taylor H., Chaddock C., Dell'acqua F., Handley R., Reinders A.A., et al. White matter integrity as a predictor of response to treatment in first episode psychosis. Brain 2014, 137(Pt 1):172-182.
101. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 1988, 9(4):339-349.
102. Rousset C.I., Chalon S., Cantagrel S., Bodard S., Andres C., Gressens P., et al. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr. Res. 2006, 59(3):428-433.
103. Samartzis L., Dima D., Fusar-Poli P., Kyriakopoulos M. White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies. J. Neuroimaging 2014, 24(2):101-110.
104. Sanfilipo M., Lafargue T., Rusinek H., Arena L., Loneragan C., Lautin A., et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatry 2000, 57(5):471-480.
105. Schmitt A., Hasan A., Gruber O., Falkai P. Schizophrenia as a disorder of disconnectivity. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261(Suppl. 2):S150-S154.
106. Schnieder T.P., Dwork A.J. Searching for neuropathology: gliosis in schizophrenia. Biol. Psychiatry 2011, 69(2):134-139.
107. Segal D., Schmitz C., Hof P.R. Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathol. 2009, 117(4):385-394.
108. Shi F., Yap P.-T., Gao W., Lin W., Gilmore J.H., Shen D. Altered structural connectivity in neonates at genetic risk for schizophrenia: a combined study using morphological and white matter networks. Neuroimage 2012, 62(3):1622-1633.
109. Shi F., Yap P.T., Gao W., Lin W., Gilmore J.H., Shen D. Altered structural connectivity in neonates at genetic risk for schizophrenia: a combined study using morphological and white matter networks. Neuroimage 2012, 62(3):1622-1633.
110. Stark A.K., Uylings H.B., Sanz-Arigita E., Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry 2004, 161(5):882-888.
111. Steffek A.E., McCullumsmith R.E., Haroutunian V., Meador-Woodruff J.H. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr. Res. 2008, 103(1-3):71-82.
112. Steiner J., Mawrin C., Ziegeler A., Bielau H., Ullrich O., Bernstein H.G., et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006, 112(3):305-316.
113. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42(2):151-157.
114. Straube B., Green A., Sass K., Kircher T. Superior Temporal Sulcus Disconnectivity During Processing of Metaphoric Gestures in Schizophrenia. Schizophr. Bull. 2013.
115. Streit W.J., Mrak R.E., Griffin W.S. Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 2004, 1(1):14.
116. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res. 2008, 102(1-3):1-18.
117. Taylor D.L., Pirianov G., Holland S., McGinnity C.J., Norman A.L., Reali C., et al. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J. Neurosci. Res. 2010, 88(8):1632-1644.
118. Tepest R., Schwarzbach C.J., Krug B., Klosterkotter J., Ruhrmann S., Vogeley K. Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2013, 263(1):15-24.
119. Thompson M., Weickert C.S., Wyatt E., Webster M.J. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J. Psychiatr. Res. 2009, 43(11):970-977.
120. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362(9386):798-805.
121. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997, 28(1):1-38.
122. Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2007, 33(3):729-736.
123. Uranova N. Damage and loss of oligodendrocytes are crucial in the pathogenesis of schizophrenia and mood disorders (findings form postmortem studies). In: Abstracts of the 43rd Annual Meeting of the American College of Neuropsychopharmacology (ACNP). December 12-16, 2004, San Juan, Puerto Rico. Neuropsychopharmacology 2004, 29(Suppl 1):S1-S267. [abstract].
124. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 2001, 55(5):597-610.
125. Uranova N.A., Orlovskaya D.D., Vostrikov V.M., Rachmanova V.I. Decreased density of oligodendroglial satellites of pyramidal neurons in layer III in the prefrontal cortex in schizophrenia and mood disorders. In: Abstracts of the XIth Biennial Winter Workshop on Schizophrenia. Davos, Switzerland, February 24-March 1, 2002. Schizophr. Res. 2002, 53(3 Suppl):1-274. [abstract].
126. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004, 67(2-3):269-275.
127. Uranova N.A., Vikhreva O.V., Rachmanova V.I., Orlovskaya D.D. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr. Res. Treat. 2011, 2011:325789.
128. van Berckel B.N., Bossong M.G., Boellaard R., Kloet R., Schuitemaker A., Caspers E., et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64(9):820-822.
129. Van Berckel B.N., Van Der Doef T., Yaqub M., Bossong M.M., Boellaard R., Van Haren N.E., et al. Neuroinflammation in temporal cortex in patients with schizophrenia measured with (R)-[11C]PK11195 and PET. Neuropsychopharmacology 2011, 36:S279.
130. Van Der Doef T.F., Bossong M., Yaqub M., Boellaard R., Kloet R.W., Schuitemaker A., et al. Focal microglial activation in schizophrenia. Schizophr. Bull. 2011, 37:129.
131. Vostrikov V.M., Uranova N.A., Rakhmanova V.I., Orlovskaia D.D. Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 2004, 104(1):47-51.
132. Wang Y., Wang Q., Haldar J.P., Yeh F.C., Xie M., Sun P., et al. Quantification of increased cellularity during inflammatory demyelination. Brain 2011, 134(Pt 12):3590-3601.
133. Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., Yolken R.H. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav. Immun. 2001, 15(4):388-400.
134. Wei H., Zou H., Sheikh A.M., Malik M., Dobkin C., Brown W.T., et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J. Neuroinflammation 2011, 8:e52.
135. Whalley H.C., Simonotto E., Marshall I., Owens D.G., Goddard N.H., Johnstone E.C., et al. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain 2005, 128(Pt 9):2097-2108.
136. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013, 382(9904):1575-1586.
137. Whitford T.J., Kubicki M., Shenton M.E. Diffusion tensor imaging, structural connectivity, and schizophrenia. Schizophr. Res. Treat. 2011, 2011:709523.
138. Wible C.G., Anderson J., Shenton M.E., Kricun A., Hirayasu Y., Tanaka S., et al. Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study. Psychiatry Res. 2001, 108(2):65-78.
139. Wible C.G., Kubicki M., Yoo S.S., Kacher D.F., Salisbury D.F., Anderson M.C., et al. A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. Am. J. Psychiatry 2001, 158(6):938-943.
140. Wierzba-Bobrowicz T., Lewandowska E., Lechowicz W., Stepien T., Pasennik E. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol. 2005, 43(2):81-89.
141. Williams M.R., Hampton T., Pearce R.K., Hirsch S.R., Ansorge O., Thom M., et al. Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2013, 263(1):41-52.
142. Williams M., Pearce R.K., Hirsch S.R., Ansorge O., Thom M., Maier M. Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2014, 264(4):357-362.
143. Wolkin A., Choi S.J., Szilagyi S., Sanfilipo M., Rotrosen J.P., Lim K.O. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am. J. Psychiatry 2003, 160(3):572-574.
144. Yang Y., Fung S.J., Rothwell A., Tianmei S., Weickert C.S. Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol. Psychiatry 2011, 69(1):63-70.
145. Yao L., Lui S., Liao Y., Du M.Y., Hu N., Thomas J.A., et al. White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 45:100-106.
146. Yolken R.H., Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin. Microbiol. Rev. 1995, 8(1):131-145.